On a recent Thursday, an 8-3 decision by a federal advisory board on vaccinations suggested the postponement of the combination vaccine against measles, mumps, rubella, and varicella (MMRV) till at least age 4. The decision traces back to longstanding evidence pointing to a slightly increased possibility of febrile seizures in children pertaining to that age group. While such seizures, though alarming, are typically brief and harmless, experts are expressing concern. They fear that this decision might result in lower immunization rates against some of the gravest diseases plaguing children: measles, mumps, and rubella.
The governmental entity known as the Advisory Committee on Immunization Practices (ACIP) plays a critical role in guiding the US Centers for Disease Control and Prevention (CDC) on matters relating to vaccine use. Normally, the CDC acts upon these recommendations, exerting a significant influence on state-level regulations for school immunizations, health insurance coverage of vaccines, and their availability at pharmacies. The implications of these recommendations had seemingly escaped the understanding of at least one panel member.
This outcome from the Thursday’s ballot indicates a reformation in the vaccine policy. The recently-appointed HHS Secretary Kennedy has quickly introduced limitations on who is eligible for Covid-19 vaccines, apart from disbanding all 17 existing ACIP members. Their replacements consist of 12 new members, some of whom were appointed just the same week.
The topic under the committee’s evaluation was whether or not to advise against administering the combinational MMRV vaccine before a child turns four. Additionally, the panel was also mulling over the possibility of deferring the initial dose of Hepatitis B vaccine until the child has aged a month.
Parents are offered two choices for immunizing their children against measles, mumps, rubella, and varicella (chickenpox) in the U.S. The options include a combined shot, referred to as MMRV, or two separate shots—one for MMR and another for chickenpox. The majority of parents, nearly 85%, opt for the separate shots.
The preventive vaccine for Hepatitis B is traditionally administered in U.S. hospitals shortly after the birth of a child due to the risk of the virus being passed on during delivery. Hepatitis B poses a severe threat, potentially leading to cirrhosis and cancer. Approximately 25,000 newborns in the U.S. annually have mothers who tested positive for Hepatitis B at the time of delivery. Non-vaccinated infants are at extreme risk—up to 90%—of developing long-term infections. The World Health Organization encourages providing a universal dose of the Hepatitis B vaccine at birth.
For years, the risk has been known, and it is advised by CDC that health care providers discuss with parents the choice between the combined MMRV vaccine and separate ones.
Experts have noted a minor rise in the occurrence of febrile seizures after administering the first dose of both the MMR and the MMRV vaccines. This risk is marginally higher after the first dose of the MMRV combination vaccine. However, the studies have yet to find an increase in the risk of seizures following the varicella vaccine.
It needs to be noted that there’s no risk of febrile seizures proven to be associated with the MMRV vaccine in children in the age bracket of 4 to 6 years, which is when the second dose is administered.
Meissner, a dissenting voter and a professor of pediatrics at Dartmouth College, echoed what had been discussed when ACIP first broached the issue in 2008. This was around the time preliminary data on a potential increase in the risk of febrile seizures was emerging. The MMRV vaccine had received licensing for the U.S. market in 2005.
He cautioned against the decrease in parental choices that resulted from recommending against the combined MMRV vaccine for children under the age of 4. He stressed that parents should be trusted with the decision, as some may prefer a single dose over two for the same level of protection. He questions why this choice should be taken away from parents.
Another voting member, Hibbeln, a psychiatrist and neuroscientist who previously served at the National Institutes of Health, expressed concerns that the elimination of a vaccination option against measles, mumps, and rubella could exacerbate the already reduced overall child vaccination rates. For Hibbeln, any changes to the policy must be backed with sound justification.
A pediatrician and professor of population and family health pointed out that while many pediatricians separately administer MMR and varicella for the first dose as is standard, there isn’t a compelling reason to amend the guidelines. He believes that after a discussion of the risks, the choice should be left to parents or caregivers who prefer the combined vaccine.
Despite their recommendation against the administration of the MMRV vaccine to children younger than 4, the advisory committee voted in an 8 to 1 decision, albeit with one abstaining vote, to continue including this vaccine in the Vaccines for Children scheme. This federal initiative provides vaccines free of cost to children without insurance or from low-income families. However, this decision could still impact coverage by private insurance providers and access to the MMRV vaccine at pharmacies.
The post Federal Advisory Board Recommends Delaying MMRV Vaccine appeared first on Real News Now.
About Author
